OncoMatch/Clinical Trials/NCT06323473

Maitake for Integrative Cancer Care

Is NCT06323473 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for cancer.

Phase 2RecruitingThe Canadian College of Naturopathic MedicineNCT06323473Data as of May 2026

Maitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.

Check if I qualify

Extracted eligibility criteria

Prior therapy

Cannot have received: mushroom supplement

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify